Evidence map›Paper›PMID 36040491›Full record

ArticleRheumatology international2022

Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis.

Francesco Cattelan, Elvis Hysa, Emanuele Gotelli, Carmen Pizzorni, Pietro Francesco Bica, Marco Grosso, Emanuela Barisione, Sabrina Paolino, Luca Carmisciano, Alberto Sulli and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Rheumatology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease's microvascular landscape.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  3. Article
  4. Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Francesco Cattelan *Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.
Elvis Hysa *Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.ORCID 0000-0002-6970-0983
Emanuele GotelliLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.ORCID 0000-0002-4732-0306
Carmen PizzorniLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.ORCID 0000-0001-5125-0200
Pietro Francesco BicaLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.
Marco GrossoPneumology Unit, IRCCS San Martino Polyclinic, Genoa, Italy.
Emanuela BarisionePneumology Unit, IRCCS San Martino Polyclinic, Genoa, Italy.ORCID 0000-0001-5365-134X
Sabrina PaolinoLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.ORCID 0000-0001-9269-5089
Luca CarmiscianoDepartment of Health Sciences, University of Genova, Genoa, Italy.ORCID 0000-0001-6263-3864
Alberto SulliLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy.ORCID 0000-0003-3674-4880
Vanessa SmithUnit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium.ORCID 0000-0001-6271-7945
Maurizio CutoloLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCSS San Martino Polyclinic, Viale Benedetto XV, 6, 16132, Genoa, Italy. mcutolo@unige.it.ORCID 0000-0002-5396-0932
Ospedale Policlinico San Martino · ITGhent University Hospital · BEUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We described nailfold videocapillaroscopy (NVC) findings and estimated the prevalence of serum anti-nuclear (ANA) and extractable nuclear antigen autoantibodies (ENA) in a cohort of sarcoidosis patients, comparing them with adequate healthy controls (HCs) and with primary Raynaud's phenomenon patients (PRPs). NVC findings were also correlated with the occurrence of autoantibodies, current treatment, laboratory parameters, variables of lung function and whole-body imaging data. Twenty-six patients with sarcoidosis were assessed through NVC, laboratory parameters, pulmonary function tests, chest-X ray and 18- fluorodeoxyglucose positron emission tomography/computed tomography. The NVC parameters and ANA/ENA dosage were recorded also in 30 PRPs and 30 HCs. Sarcoidosis patients showed a higher rate of capillary dilations and nonspecific abnormalities and a lower mean capillary absolute number than PRPs and HCs (p < 0.01 for all comparisons). The prevalence of ANA positivity was higher in patients with sarcoidosis compared with PRPs and HCs (p < 0.02 for both), whereas ENA positivity was detected in one sarcoidosis patient (Ro52). Among sarcoidosis patients, the mean capillary absolute number negatively correlated with the C-reactive protein concentrations and was positively associated with the forced vital capacity percentage. Instead, a negative correlation was detected between serum ACE levels and the presence of capillary dilations (all p < 0.05). Our findings suggest a microvascular involvement in sarcoidosis whose investigation by NVC might be useful for the follow-up of patients displaying RP. Autoantibody positivity in sarcoidosis might suggest autoimmune implications in the disease or the production of autoantibodies reactive to tissue damage.

Indexed as

Raynaud DiseaseSarcoidosisScleroderma, SystemicAntigens, NuclearAutoantibodiesCapillariesC-Reactive ProteinHumansMicroscopic AngioscopyNailsAntigens, NuclearAutoantibodiesC-Reactive ProteinAntinuclear antibodiesMicrocirculationMicroscopic angioscopySarcoidosis

Identifiers

PMID36040491
PMCPMC9548476
OpenAlexW4293576382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.